Literature DB >> 25982082

The Formation of Marijuana Risk Perception in a Population of Substance Abusing Patients.

Samuel T Wilkinson1, Gerrit I van Schalkwyk2, Larry Davidson3, Deepak C D'Souza3,4,5.   

Abstract

Risk perception has been shown to be protective with regard to marijuana use. Notably, the risk perception of marijuana in individuals with substance abuse problems varies significantly from that of the general public. Understanding how risk perception is formed in substance users could explain these differences and help predict the consequences of policy changes. Using this framework, we explored risk perception and its formation in a sample of substance abusing veterans. Semi-structured interviews were conducted with veterans who were receiving treatment for substance abuse. Interviews were recorded digitally, transcribed verbatim, and analyzed using inductive thematic analysis. A prominent perspective among the 31 participants was that marijuana is significantly different from other drugs because it is safe, not addictive, not associated with physical withdrawal, and has less overt behavioral effects than other substances. Many of these participants drew upon their own innocuous experiences with the drug in developing this perspective, more so than information from any other source. A contrasting narrative emphasized marijuana's capacity to cause negative social consequences, act as a gateway to the use of other, more harmful substances, and cause paranoia or worsen psychosis. In conclusion, individual experience with marijuana featured more prominently in informing risk perception than any other source of information. Our results and previous literature suggest that the significant disconnect between the individual experiences of substance users and the current clinical and legal policy towards marijuana may weaken the legitimacy of public policy or the authority of the medical community.

Entities:  

Keywords:  Drug policy; Legalization; Marijuana; Marijuana abuse; Substance abuse; Veterans

Mesh:

Year:  2016        PMID: 25982082     DOI: 10.1007/s11126-015-9369-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  21 in total

1.  Physicians and medical marijuana.

Authors:  Herbert D Kleber; Robert L DuPont
Journal:  Am J Psychiatry       Date:  2012-06       Impact factor: 18.112

2.  Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Addiction       Date:  2006-04       Impact factor: 6.526

Review 3.  Systematic review and meta-analysis of cannabis treatment for chronic pain.

Authors:  Eva Martín-Sánchez; Toshiaki A Furukawa; Julian Taylor; Jose Luis R Martin
Journal:  Pain Med       Date:  2009-09-01       Impact factor: 3.750

Review 4.  Adverse health effects of non-medical cannabis use.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  Lancet       Date:  2009-10-17       Impact factor: 79.321

5.  The perceived health risks of cannabis use in an Australian household survey.

Authors:  Bianca Calabria; Wendy Swift; Tim Slade; Wayne Hall; Jan Copeland
Journal:  Drug Alcohol Rev       Date:  2012-03-04

6.  Early adolescent marijuana use: risks for the transition to young adulthood.

Authors:  J S Brook; R E Adams; E B Balka; E Johnson
Journal:  Psychol Med       Date:  2002-01       Impact factor: 7.723

7.  Public opinion and drug policy in Australia: engaging the 'affected community'.

Authors:  Kari Lancaster; Alison Ritter; Jennifer Stafford
Journal:  Drug Alcohol Rev       Date:  2012-08-16

8.  Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

Authors:  David A Gorelick; Robert S Goodwin; Eugene Schwilke; David M Schwope; William D Darwin; Deanna L Kelly; Robert P McMahon; Fang Liu; Catherine Ortemann-Renon; Denis Bonnet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-10-16       Impact factor: 3.367

Review 9.  Adverse effects of cannabis on health: an update of the literature since 1996.

Authors:  Harold Kalant
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-08       Impact factor: 5.067

10.  The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study.

Authors:  Judith S Brook; Matthew A Stimmel; Chenshu Zhang; David W Brook
Journal:  Am J Addict       Date:  2008 Mar-Apr
View more
  6 in total

1.  Longitudinal associations between negative urgency, symptoms of depression, cannabis and alcohol use in veterans.

Authors:  Rachel L Gunn; Angela K Stevens; Lauren Micalizzi; Kristina M Jackson; Brian Borsari; Jane Metrik
Journal:  Exp Clin Psychopharmacol       Date:  2020-03-05       Impact factor: 3.157

2.  Cannabis Use and Anxiety Sensitivity in Relation to Physical Health and Functioning in post-9/11 Veterans.

Authors:  Kate L Stewart; Samantha G Farris; Kristina M Jackson; Brian Borsari; Jane Metrik
Journal:  Cognit Ther Res       Date:  2018-08-09

Review 3.  Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Aaron L Sarvet
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

4.  A reciprocal effects analysis of cannabis use and perceptions of risk.

Authors:  Naji C Salloum; Melissa J Krauss; Arpana Agrawal; Laura J Bierut; Richard A Grucza
Journal:  Addiction       Date:  2018-03-02       Impact factor: 6.526

5.  Medicinal versus Recreational Cannabis Use among Returning Veterans.

Authors:  Jane Metrik; Shayna S Bassett; Elizabeth R Aston; Kristina M Jackson; Brian Borsari
Journal:  Transl Issues Psychol Sci       Date:  2018-03

6.  Examining motivational pathways from adult attention-deficit/hyperactivity disorder symptoms to cannabis use: Results from a prospective study of veterans.

Authors:  Angela K Stevens; Rachel L Gunn; Kristina M Jackson; Brian Borsari; Jane Metrik
Journal:  Psychol Addict Behav       Date:  2020-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.